FinancialContent is the trusted provider of stock market information to the media industry.
Adaptive Biotechnologies IPO: Five things to know
Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public.
Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.